Summary:
Production of the Sputnik V vaccine against Coronavirus will begin in India this summer the Russian Direct Investment Fund (RDIF) and pharmaceutical company Panacea Biotec announced on Monday. Sputnik V was registered in India under the emergency use authorisation procedure on April 12 and vaccination against coronavirus with the Russian vaccine started on May 14. “Launch of production in India in partnership with Panacea Biotec marks an important step for helping the country fight the pandemic. The RDIF has signed a deal to produce 750 million doses of Sputnik V in India. The price of Sputnik V is less than $10 per shot making it affordable around the world..